Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Q-Wave Myocardial Infarction.

Coppola1, Ambrose

  • 1Saint Vincents Hospital and Medical Center, 153 West 11th Street, Cronin 5-553, New York, NY 10011, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The importance of the internal anal sphincter (IAS) in maintaining continence: anatomical, physiological and pharmacological considerations.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Same author

Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study.

Climacteric : the journal of the International Menopause Society·2006
Same author

Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy.

Maturitas·2005
Same author

Improved branching ratio measurement for the decay K(0)(L) --> &mgr;(+)&mgr;(-)

Physical review letters·2000
Same author

Blood viscosity and aging.

Archives of gerontology and geriatrics·2000
Same author

PROFILE: Wetland Mitigation Banking: A Framework for Crediting and Debiting.

Environmental management·2000

Treatment for non-Q-wave infarction uses antithrombotics and antianginals. High-risk patients may benefit from glycoprotein IIb/IIIa inhibitors, while risk stratification guides invasive evaluation and revascularization decisions.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Non-Q-wave myocardial infarction management has evolved with new therapeutic options.
  • Risk stratification is crucial for determining appropriate treatment pathways.

Purpose of the Study:

  • To review current treatment strategies for non-Q-wave infarction.
  • To discuss the evolving role of angiography and revascularization.
  • To emphasize individualized therapy based on risk-benefit assessment.

Main Methods:

  • Review of current medical literature and clinical guidelines.
  • Discussion of antithrombotic, antianginal, and newer pharmacologic agents.
  • Analysis of risk stratification criteria and invasive versus noninvasive testing strategies.

Main Results:

Related Experiment Videos

  • Antithrombotic therapy (aspirin, heparin) and antianginal medications are standard.
  • Platelet glycoprotein IIb/IIIa antagonists are indicated for high-risk subgroups.
  • Risk stratification allows for tailored approaches, favoring noninvasive testing in low-risk patients and angiography in high-risk patients.

Conclusions:

  • Individualized therapy is paramount, considering patient-specific risk-benefit profiles.
  • Percutaneous coronary intervention, especially with glycoprotein IIb/IIIa inhibitors and stents, is expanding.
  • Further clinical trials are needed to establish evidence-based future therapies.